State Street’s Entrada Therapeutics TRDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.74M Buy
533,798
+25,009
+5% +$287K ﹤0.01% 2812
2025
Q4
$5.23M Buy
508,789
+10,174
+2% +$85.8K ﹤0.01% 2973
2025
Q3
$2.89M Buy
498,615
+2,753
+0.6% +$16.1K ﹤0.01% 3218
2025
Q2
$3.33M Buy
495,862
+1,474
+0.3% +$11.9K ﹤0.01% 3110
2025
Q1
$4.47M Sell
494,388
-10,591
-2% -$132K ﹤0.01% 2927
2024
Q4
$8.73M Buy
504,979
+35,378
+8% +$641K ﹤0.01% 2707
2024
Q3
$7.5M Buy
469,601
+24,385
+5% +$384K ﹤0.01% 2766
2024
Q2
$6.34M Buy
445,216
+9,826
+2% +$140K ﹤0.01% 2815
2024
Q1
$6.17M Buy
435,390
+7,558
+2% +$107K ﹤0.01% 2837
2023
Q4
$6.46M Buy
427,832
+24,579
+6% +$364K ﹤0.01% 2823
2023
Q3
$6.37M Buy
403,253
+12,062
+3% +$190K ﹤0.01% 2812
2023
Q2
$5.92M Buy
391,191
+326,614
+506% +$4.5M ﹤0.01% 2914
2023
Q1
$936K Buy
64,577
+54
+0.1% +$721 ﹤0.01% 3549
2022
Q4
$872K Buy
64,523
+31,229
+94% +$547K ﹤0.01% 3589
2022
Q3
$525K Buy
33,294
+3,100
+10% +$39.4K ﹤0.01% 3762
2022
Q2
$368K Sell
30,194
-121,000
-80% -$918K ﹤0.01% 3959
2022
Q1
$1.42M Buy
151,194
+70,075
+86% +$751K ﹤0.01% 3692
2021
Q4
$1.39M Buy
+81,119
New +$1.97M ﹤0.01% 3741

Other funds holding TRDA